Corporate
  • bioMérieux

    Created in 1963
  • Social networks

    1,684 310,295
  • Sectors

  • Location

    100 All. Louis Raymond, 69280 Marcy-l'Étoile, France

    Marcy-l'Étoile

    France

  • Engaged entities

    247
    181 48
  • Added in Motherbase

    18 Sep 2019, 4:49 p.m.
Description
  • Value proposition

    Pioneering Diagnostics

    Pioneering Diagnostics

    A world leader in the field of in vitro diagnostics for 60 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors.

    In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France.

    bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety.

    Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.

    bioMérieux is listed on the Euronext Paris stock market.

    Symbol: BIM – ISIN Code: FR0013280286
    Reuters: BIOX.PA/Bloomberg: BIM.FP


    in vitro diagnostics, infectious diseases, reagents, automated instruments, medical analysis, cosmetics, pharmaceutical, industries, healthcare associated infections, molecular biology, microbiology, immunoassays, antimicrobial stewardship, rapid diagnostics, food safety, veterinary diagnostics, blood bank, and sepsis

  • Original language

    Pioneering Diagnostics

    Pioneering Diagnostics

    A world leader in the field of in vitro diagnostics for 60 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors.

    In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France.

    bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety.

    Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.

    bioMérieux is listed on the Euronext Paris stock market.

    Symbol: BIM – ISIN Code: FR0013280286
    Reuters: BIOX.PA/Bloomberg: BIM.FP

Entity interactions BETA
Entity TypeTweets Articles
AIRVANCE Group AIRVANCE Group
Other

24 Apr 2024


Oroxcell Oroxcell
biotech, deeptech, Biotechnology Research
Other

3 Apr 2024


JobPass JobPass
HRtech, Software Development
Other

16 Apr 2024


Azbil Telstar Azbil Telstar
constructiontech, manufacturing, Machinery Manufacturing
Other

22 Apr 2024


International Pharmaceutical Federation (FIP) International Pharmaceutical Federation (FIP)
healthtech, Non-profit Organizations
Other

14 Apr 2024


Indo-French Chamber of Commerce & Industry (IFCCI) Indo-French Chamber of Commerce & Industry (IFCCI)
e-commerce, International Trade and Development
Other

22 Apr 2024


Utah Governor's Office of Economic Opportunity Utah Governor's Office of Economic Opportunity
Government Administration
Other

21 Apr 2024


Investinor Investinor
Venture Capital and Private Equity Principals
Other

29 Feb 2024


Eurobio Scientific Eurobio Scientific
biotech, deeptech, Biotechnology Research
Other

3 Apr 2024


EPPUR EPPUR
manufacturing, healthtech, Hospitals and Health Care
Other

5 Apr 2024


Radars
Loading...